Chronic inflammatory demyelinating polyneuropathy (CIDP)

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-related neurological condition that causes damage to peripheral nerves. Most patients are diagnosed between the ages of 40 and 60. In CIDP, nerve damage causes progressive leg and arm weakness that makes it difficult to walk, go up stairs, and perform fine motor skills. Current treatments for CIDP do not work for everyone, so new treatments are still needed.

The latest on our research

AllStripes recently completed our first research project for CIDP by matching eligible patients with an ongoing phase II clinical trial. This was the first time AllStripes was involved in a phase II trial, and we learned a lot we will carry forward to improve the process in the future. We plan to continue our CIDP program and take on new research initiatives whenever possible.